237 Users Online
Urinary Catheters Market by Product (Intermittent Catheter, Indwelling (Foley) Catheter and External Catheter)
The Global revenue from the Urinary Catheters Market was about US$ 1.8 Billion in 2022, with the global market expected to grow at a CAGR of 5.3% to reach a valuation of about US$ 3.2 Billion by the end of 2033.
Market Size (2023)
US$ 1.9 Billion
Projected Market Value (2033)
US$ 3.2 Billion
Global Market Growth Rate (2023 to 2033)
Market Share of Top 5 Countries (2022)
As assessed by Persistence Market Research, intermittent catheter held a market share of around 57.2% in the global market, in 2022. Overall, the sales for urinary catheters market accounted for around 5.7% of revenue share in the global urology device market, which was valued at around US$ 31.6 Billion in 2022.
Urinary catheterization involves inserting a silicone, polyurethane, or latex tube inserted into bladder through urethra for collection of urine in drainage bag. It also has use in injection of liquids (medicated liquid/solution) for bladder diagnosis and treatment. Except for clinicians and nurses, self-catheterization is also possible. A catheter can be left in place for long-term period of time (indwelling catheter) or it can be removed after every use (intermittent Catheter).
Depending on the approach of insertion, urinary catheters are classified as external (attached to external genitalia), urethral (tip inserted into the bladder base through urethra), or suprapubic (inserted into the bladder surgically through suprapubic approach).
The global urinary catheters market recorded a historic CAGR of 4.1% in the last 8 years from 2014 to 2022 due to the increasing prevalence of urological disorders and the demand for more advanced and patient-friendly catheterization options.
The growing incidence of urological disorders such as urinary incontinence, bladder cancer, and prostate cancer has resulted in a greater demand for urinary catheters. The global aging population has increased, and elderly individuals are more prone to urological disorders that can require the use of catheters.
There have been significant technological advancements in the design and development of urinary catheters, such as antimicrobial coatings, improved drainage systems, and minimally invasive catheterization procedures. There has been a growing trend towards the development of advanced urinary catheters that are more comfortable, convenient, and reduce the risk of infections. Many companies have been investing in Research and Development of innovative products that are easy-to-use and improve patient outcomes. These innovations have increased the adoption of catheterization procedures.
The demand for home healthcare services has increased, particularly for the elderly population. This has led to an increase in the use of urinary catheters at home, as these devices are easy-to-use and require minimal medical supervision.
Governments around the world are implementing initiatives to improve the quality of care for patients with urological disorders. This includes guidelines and protocols for the use of catheters in healthcare settings.
“Increasing the Prevalence of Chronic Diseases Require Some Degree of Catheterization”
Increasing prevalence of chronic diseases or comorbidities, especially in elderly population requires at least small degree of catheterization.
Governments of various countries across the globe are focusing on providing favorable reimbursement policies for caregivers and patients spending on urinary catheters. Under these policies, costs incurred on urinary continence products such as urinary catheters and absorbent products (e.g, diapers) can be fully or partially reimbursed through public and private insurance programs. This is resulting in increased adoption of urinary catheters. For instance, Medicarereimbursement coverage by the United States government allows reimbursement of maximum 200 sterile intermittent catheters every month. This reimbursement is useful to Americans with low-income families, elder people, disable people, and pregnant women
“Absorbent Products’ Reimbursements and Catheters-Associated Infections”
Growing incidence of UTIs associated with the use of urinary catheters, which has become a challenge for healthcare system.
The availability and accessibility of disposable incontinence products, especially for external catheters, such as adult diapers, absorbent pants, is predicted to restrain the growth of the urinary catheter market globally.
Government policies in the United States, the United Kingdom, and Australia, and other nations have also been providing a variety of reimbursement programs for disposable incontinence products purchase, which is anticipated to restrain market development over the forecast period.
Why is the United States Market Booming?
“Reimbursement Policies, and Government’s Disease Guideline to Reduce CAUTI”
The United States market held around 36.0% of global market share in 2022 due to increased patient pool and government policies to reimburse the healthcare expenses and to reduce CAUTI.
In the United States people are using urinary catheters for various urinary tract problems.
Other growth factors are like government reimbursement policies and advancement development of products, and increasing awareness, all are contributing to expansion of the global market. The United States government is also taking care to reduce the CAUTI.
Will the United Kingdom Be a Lucrative Market for Urinary catheters?
“Bladder Cancer and Prostate Cancer Prevalence and Growing Awareness”
The United Kingdom market held around 10.6% market share of the global market in 2022 due to growing awareness about the use of catheterization and prevalence of bladder cancer and prostate cancer.
The United Kingdom has a relatively high prevalence of urological disorders such as urinary incontinence, bladder cancer, and prostate cancer. These conditions often require the use of urinary catheters as part of the treatment.
There is a growing awareness about the importance of proper catheterization procedures and the risks associated with urinary tract infections.
The United Kingdom government has implemented several initiatives to improve the quality of care for patients requiring urinary catheterization.
How is China Emerging as a Prominent Market?
“Aging Population with LUTS and Government’s Initiatives to Improve Quality of Care”
China held a market share of about 6.1% of the global market in 2022 and will expand in the forecast period due to increased patient pools and government is implementing initiatives to improve the quality of care during urinary catheterization.
China has a rapidly aging population, and this demographic group is more likely to require urinary catheters due to conditions such as urinary incontinence and urinary retention. There is a growing awareness in China about the importance of proper catheterization procedures and the risks associated with urinary tract infections.
The Chinese government has implemented several initiatives to improve the quality of care for patients requiring urinary catheterization.
Which Product is Driving Demand Within the Global Market?
“Intermittent Catheter Is a Short-Term Catheter and Hence Increases Active Lifestyle”
Intermittent catheter had about 57.2% share in the global market in 2022 as it involves the periodic insertion and removal of a catheter to avoid risk of urinary tract infections.
Intermittent catheter is a flexible catheter used to empty the bladder at regular intervals. Intermittent catheterization is a relatively easy process. In comparison to a consistently draining catheter, intermittent catheterization is an effective way to avoid UTI, bladder enlargement, or inflammation. It helps to increase active lifestyle and improves UI because it can be removed once the bladder is empty, or after ever use. Infection, blockage, leakage, and bladder spasm are all reduced with intermittent catheters. Intermittent catheters can be coated, non-coated or pre-lubricated and do not have a balloon attachment at the tip like indwelling catheter.
Which Application of Urinary Catheter Is Helping to Expand the Global Market?
“Catheterization Allow the Urethra to Heal and Reduce the Complications”
By application segment, prostate gland surgery held 37.8% share of the global market in 2022 due to catheterization allow the urethra to heal and reduce the risk of complications after prostate gland surgery.
Urinary catheterization is a common procedure that is often used in prostate gland surgery, such as a radical prostatectomy or transurethral resection of the prostate (TURP). During these procedures, a catheter is inserted into the urethra and guided through the prostate gland to drain urine from the bladder.
The prostate gland surgery can cause swelling or damage to the urethra, making it difficult or impossible for the patient to urinate normally. The catheter can help to prevent the buildup of urine in the bladder, which can cause discomfort and potentially lead to complications such as UTIs.
A catheter can be left in place for a few days following prostate gland surgery to allow the urethra to heal and reduce the risk of complications. The length of time that the catheter is left in place will depend on the type of surgery performed and the patient's individual circumstances.
To expand their customer base and increase business revenue, key players are focusing on mergers and acquisitions as well as innovative product launches. The market players are focusing on Research and Development to develop technologically advanced products in the market. Rapid technology changes and development of new products by other companies provide company product less competitive.
A few examples of strategies acquired by the key players:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the urinary catheters market, which are available in the full report.
2023 to 2033
Historical Data Available for
2014 to 2022
Key Countries Covered
Key Market Segments Covered
Key Companies Covered
Customization & Pricing
Available upon Request
The global market is valued at around US$ 1.8 Billion in 2022.
The global market estimates for 2023 is around US$ 1.9 Billion in 2023
The global market is set to reach valuation of around US$ 3.2 Billion by the end of 2033.
Sales of the market is set to witness growth at a CAGR of 5.3% between 2023 and 2033.
Demand for the global market increased at 4.1% CAGR from 2014 to 2022.
B. Braun Melsungen AG, Coloplast A/S, Becton, Dickinson and Company, Teleflex Incorporation, Boston Scientific Corporation, Medtronic plc., Hollister Incorporate, Cook Medical, Catherix, and UroDev Medical are the key players of the global market.
The U.S., China, Germany, the U.K., and Japan cumulatively contribute 70.5% revenue share to the global market in 2022.
The U.S. accounts for around 36.0% share of the global market in 2022.
China accounts for around 6.1% share of the global market in 2022 and will expand the market in the forecast period.
Intermittent catheter had about 57.2% share in the global market in 2022.
The urinary catheters market in the U.K. is holding 10.6% market share in 2022.